Shows
Obesity: A DiseaseEpisode 113: Article Reviews: Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight managementIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews David Despain, MSc/MSc, CFS. Our experts discuss the Obesity Pillars Article Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: A qualitative research study with registered dietitians for which David is a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of cl...
2025-06-2624 min
CME/CETargeting Mixed Hyperlipidemia with APOC3 Inhibition
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Kausik Ray, MBChB, MD, MPhil
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3000 minCME/CEThe Road Ahead: What's on the Horizon for FCS and SHTG Management
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Prof. Kausik Ray
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3000 minCME/CESHTG: Decoding the Latest Clinical Trial Outcomes
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Kausik Ray, MBChB, MD, MPhil
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3000 minCME/CELatest Clinical Trial Outcomes and Breakthroughs for FCS
Guest: Daniel Gaudet, MD, PhD
Guest: Pam R. Taub, MD, FACC, FASPC
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3000 minCME/CESHTG: Defining the Unmet Clinical Need
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Kausik Ray, MBChB, MD, MPhil
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3000 minCMEThe Road Ahead: What's on the Horizon for FCS and SHTG Management
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Prof. Kausik Ray
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3004 minCMETargeting Mixed Hyperlipidemia with APOC3 Inhibition
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Kausik Ray, MBChB, MD, MPhil
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3004 minCMESHTG: Decoding the Latest Clinical Trial Outcomes
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Kausik Ray, MBChB, MD, MPhil
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3005 minCMESHTG: Defining the Unmet Clinical Need
Guest: Pam R. Taub, MD, FACC, FASPC
Guest: Kausik Ray, MBChB, MD, MPhil
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3005 minCMELatest Clinical Trial Outcomes and Breakthroughs for FCS
Guest: Daniel Gaudet, MD, PhD
Guest: Pam R. Taub, MD, FACC, FASPC
There is an unmet need for patients with FCS, SHTG, and mixed hyperlipidemia, as most patients are non-responsive to current standard of care. Recent developments on APOC3 inhibition show promising results for the management of these patient groups. Four experts discuss the characteristics, diagnostic criteria and the risks of patients with FCS, SHTG, and mixed hyperlipidemia, and review the recent evidence of clinical trials with new APOC3 inhibitors.
2025-05-3003 minObesity: A DiseaseEpisode 112: Article Reviews: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with ObesityIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Sara Karjoo, MD, CPE, FOMA, DABOM. Our experts discuss the Obesity Pillars Article Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025 for which Dr. Karjoo is a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the p...
2025-05-0122 minCME/CEEstablishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Host: Rishi Wadhera, MD, MPP, Mphil
This on-demand knowledge primer explores key challenges and evidence-based strategies for improving atherosclerotic cardiovascular disease (ASCVD) management in rural populations. Led by two expert faculty members, the program provides a comprehensive overview of disparities in ASCVD care, guideline-directed therapies, and practical approaches to overcoming barriers in rural settings. Participants will gain essential knowledge to enhance patient outcomes and optimize cardiovascular care in underserved communities.
2025-04-0300 minCME/CEEstablishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Host: Rishi Wadhera, MD, MPP, Mphil
This on-demand knowledge primer explores key challenges and evidence-based strategies for improving atherosclerotic cardiovascular disease (ASCVD) management in rural populations. Led by two expert faculty members, the program provides a comprehensive overview of disparities in ASCVD care, guideline-directed therapies, and practical approaches to overcoming barriers in rural settings. Participants will gain essential knowledge to enhance patient outcomes and optimize cardiovascular care in underserved communities.
2025-04-0359 minCMEEstablishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Host: Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Host: Rishi Wadhera, MD, MPP, Mphil
This on-demand knowledge primer explores key challenges and evidence-based strategies for improving atherosclerotic cardiovascular disease (ASCVD) management in rural populations. Led by two expert faculty members, the program provides a comprehensive overview of disparities in ASCVD care, guideline-directed therapies, and practical approaches to overcoming barriers in rural settings. Participants will gain essential knowledge to enhance patient outcomes and optimize cardiovascular care in underserved communities.
2025-04-0359 minObesity: A DiseaseEpisode 110: Article Reviews: Practice AnalysisIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Kimberly Gudzune, MD, MPH, FTOS. Our experts discuss the Obesity Pillars Article Duties, tasks, knowledge and skills of an obesity medicine physician: A practice analysis, for which Dr. Gudzune is the primary author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research f...
2025-03-2717 minObesity: A DiseaseEpisode 108: Article Reviews: Obesity Medicine FellowshipIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Yuval Pinto, MD. Our experts discuss Obesity Medicine Fellowship and the Obesity Pillars article, Obesity Medicine as a Subspecialty and United States Certification – A Review. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other hea...
2025-02-2422 min
Luminaries in Structural Heart.Women and aortic stenosis, evidence practice review of the SMART trial results.
In this episode, Dr. Roxana Mehran and Dr. Martha Gulati engage in a captivating discussion about how the SMART Trial is making a difference for women with aortic stenosis.[†,1] The SMART Trial is the largest, most rigorous clinical trial to date to randomize patients to the two most widely used TAVR devices, and to enroll predominantly women.[1]
Featured faculty:
Martha Gulati, MD MS FACC FAHA FASPC FESC
Director of Preventive Cardiology and Professor of Cardiology, Cedars Sinai Smidt Heart Institute
Associate Director, Barbra Streisand Women’s Heart Center
Associate Director, Preventive and Cardiac Reha...
2025-01-2927 minObesity: A DiseaseEpisode 105: Article Reviews: Obesity and AdvocacyIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Carolynn Francavilla, MD, DABOM, FOMA. Our experts discuss the Obesity Pillars article, Obesity and Advocacy: A Joint Clinical Perspective and Expert Review from the Obesity Medicine Association and the Obesity Action Coalition, for which Dr. Francavilla was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the pu...
2024-11-2521 minObesity: A DiseaseEpisode 103: Article Reviews: Compounded PeptidesIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Courtney Younglove, MD, FOMA, FACOG, DABOM. Our experts discuss the Obesity Pillars article, Frequently asked questions to the 2023 Obesity Medicine Association Position Statement on Compounded Peptides: A call for action, for which Dr. Younglove was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of cl...
2024-10-2317 minObesity: A DiseaseEpisode 101: Article Reviews: Navigating Insurance CoverageIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Treah Haggerty. Our experts discuss the Obesity Pillars article, Navigating Coverage: A qualitative study exploring the perceived impact of an insurance company policy to discontinue coverage of antiobesity medication, for which Dr. Haggerty was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical an...
2024-09-2619 min
Decera Clinical Education Medical Specialties PodcastExpert Discussions: Novel Agents Targeting Residual Inflammatory Risk in ASCVD and CKDIn this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they discuss new and emerging therapies designed to target residual inflammatory risk associated with ASCVD and CKD. Episode outline: Colchicine: inhibition of NLRP3 inflammasome assembly/activationCanakinumab (anti–IL-1β monoclonal antibody)Ziltivekimab (anti–IL-6 monoclonal antibody)Other emerging targets/therapies To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below: CME-certified text module with animated pathophysiology video and faculty voice audio cli...
2024-08-2615 min
Decera Clinical Education Medical Specialties PodcastExpert Discussions on Residual Systemic Inflammation in ASCVD and CKDIn this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD. Episode outline: The relationship among systemic inflammation, ASCVD, and CKD The role of cardiologists and nephrologists in screening and mitigating systemic inflammation To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below: CME-certified text module with animated pathophysiology vid...
2024-08-2614 min
Decera Clinical Education Medical Specialties PodcastExpert Discussions: Moving Beyond Lipid Lowering to Lower Risk in ASCVD and CKDIn this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore the pathophysiology and novel therapeutic strategies to target residual inflammatory risk associated with ASCVD and CKD. Episode outline: Moving beyond lipid lowering to address residual inflammatory riskNovel anti-inflammatory targets for ASCVD To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below: CME-certified text module with animated pathophysiology video and faculty voice audio clipsClinicalThought commentariesPodcast episode 1, discussing residua...
2024-08-2614 minObesity: A DiseaseEpisode 99: Article Reviews: Weight Centric Prevention of CancerIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Dr. Maria Daniela Hurtado. Our experts discuss the Obesity Pillars article, Weight-Centric Prevention of Cancer, for which Dr. Hurtado was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in th...
2024-07-3026 minObesity: A DiseaseEpisode 95: Article Reviews: Obesity, Dyslipidemia, and Cardiovascular DiseaseIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Sandra Christensen, MSN, ARNP, FNP-BC, FAANP. Our experts discuss the Obesity Pillars article, Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024, for which Sandra was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of cl...
2024-06-2521 min
Heart to Heart NursesThe Changing Trajectory of Cardiovascular CareIt is an exciting time in cardiovascular prevention and management, where we can work together to make a significant difference for our patients. New pharmacotherapies are changing the disease burden and leading to improved outcomes for our patients, regardless of circumstance. Guest Clyde Yancy, MD, MSc, MACC, MACP, FAH, FHFSA, FRCP, FASPC (Hon.), FPCNA (Hon.), provides data and inspiration for our actions every day. SELECT Trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/11/09/15/04/select Health Equity Self-Assessment Tool: Take 10 minutes, identify your strengths, and get links to related re...
2024-06-1816 minCME/CEPutting Data into Clinical Practice
Host: Pam R. Taub, MD, FACC, FASPC
Guest: Steven Yakubov, MD, MSCAI, FACC
“Getting SMART about TAVR” is a comprehensive multi-episodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape and the impact of the device on patients with a small anulus, particularly women. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial data.
2024-01-3100 minCME/CEPutting Data into Clinical Practice
Host: Pam R. Taub, MD, FACC, FASPC
Guest: Steven Yakubov, MD, MSCAI, FACC
“Getting SMART about TAVR” is a comprehensive multi-episodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape and the impact of the device on patients with a small anulus, particularly women. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial data.
2024-01-3100 minCMEPutting Data into Clinical Practice
Host: Pam R. Taub, MD, FACC, FASPC
Guest: Steven Yakubov, MD, MSCAI, FACC
“Getting SMART about TAVR” is a comprehensive multi-episodic CME series addressing critical aspects of the evolving transcatheter aortic valve replacement (TAVR) landscape and the impact of the device on patients with a small anulus, particularly women. Join our experts as they discuss topics on patient identification ranging from the use of echocardiography to identify symptomatic severe aortic stenosis patients to challenging case discussions, device durability, and up-to-date clinical trial data.
2024-01-3100 min
VacciNationEquity in Flu Vaccine Rates: Bridging Racial & Ethnic Gaps
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
Vaccines are essential in reducing death and disability related to influenza, but unfortunately, not all patients have equal access to these life-saving resources. In fact, many barriers exist, like misinformation and lack of public awareness and education. That’s why Dr. Charles Turck speaks with Dr. Keith Ferdinand about ways we can break down barriers and improve vaccination rates among members of racial and ethnic minority communities.
2023-08-3100 minObesity: A DiseaseEpisode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-2818 minObesity: A DiseaseEpisode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-2818 minObesity: A DiseaseEpisode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-0717 minObesity: A DiseaseEpisode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-0717 minObesity: A DiseaseEpisode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health...
2023-05-1816 minObesity: A DiseaseEpisode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health...
2023-05-1816 minObesity: A DiseaseEpisode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-04-2615 minObesity: A DiseaseEpisode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-04-2615 min
Keeping InSightCARDIOVASCULAR | Dr. Keith C. Ferdinand | Breaking Barriers to Build Trust in Cardiovascular CareIn this episode our MSL co-hosts Dalila Masic, PharmD and Katie Mousavi, PharmD have a conversation with Keith C. Ferdinand MD, FACC, FAHA, FASH, FASPC, FNLA on how to build trust among patients and members of the cardiovascular healthcare community. Dr. Ferdinand identifies key barriers that physicians and other healthcare providers encounter when building trust with patients, especially among racial and ethnic minority populations and other marginalized communities. We conclude the episode with concrete actions and resources our listeners can use to enhance trust and begin to narrow the gap on healthcare disparities. Resources m...
2023-04-0233 minObesity: A DiseaseEpisode 78: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic RiskIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-03-2421 minObesity: A DiseaseEpisode 78: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic RiskIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-03-2421 min
PeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smarter Approaches for Diagnosing HoFHGo online to PeerView.com/BPX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While homozygous familial hypercholesterolemia (HoFH) is associated with development of atherosclerotic cardiovascular disease in childhood, early recognition and treatment of this inherited disease can improve outcomes for patients. In this animated activity provided by PeerView in collaboration with the Family Heart Foundation, a cardiologist describes the impact of this rare disease on patients and their families, presents strategies for recognizing signs and symptoms of HoFH, and reviews guidelines for genetic screening and referral of patients and their families...
2023-03-1134 min
PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smarter Approaches for Diagnosing HoFHGo online to PeerView.com/BPX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While homozygous familial hypercholesterolemia (HoFH) is associated with development of atherosclerotic cardiovascular disease in childhood, early recognition and treatment of this inherited disease can improve outcomes for patients. In this animated activity provided by PeerView in collaboration with the Family Heart Foundation, a cardiologist describes the impact of this rare disease on patients and their families, presents strategies for recognizing signs and symptoms of HoFH, and reviews guidelines for genetic screening and referral of patients and their families...
2023-03-1135 min
PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smarter Approaches for Diagnosing HoFHGo online to PeerView.com/BPX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While homozygous familial hypercholesterolemia (HoFH) is associated with development of atherosclerotic cardiovascular disease in childhood, early recognition and treatment of this inherited disease can improve outcomes for patients. In this animated activity provided by PeerView in collaboration with the Family Heart Foundation, a cardiologist describes the impact of this rare disease on patients and their families, presents strategies for recognizing signs and symptoms of HoFH, and reviews guidelines for genetic screening and referral of patients and their families...
2023-03-1134 min
PeerView Internal Medicine CME/CNE/CPE Video PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smarter Approaches for Diagnosing HoFHGo online to PeerView.com/BPX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While homozygous familial hypercholesterolemia (HoFH) is associated with development of atherosclerotic cardiovascular disease in childhood, early recognition and treatment of this inherited disease can improve outcomes for patients. In this animated activity provided by PeerView in collaboration with the Family Heart Foundation, a cardiologist describes the impact of this rare disease on patients and their families, presents strategies for recognizing signs and symptoms of HoFH, and reviews guidelines for genetic screening and referral of patients and their families...
2023-03-1135 min
PeerView Internal Medicine CME/CNE/CPE Audio PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smarter Approaches for Diagnosing HoFHGo online to PeerView.com/BPX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While homozygous familial hypercholesterolemia (HoFH) is associated with development of atherosclerotic cardiovascular disease in childhood, early recognition and treatment of this inherited disease can improve outcomes for patients. In this animated activity provided by PeerView in collaboration with the Family Heart Foundation, a cardiologist describes the impact of this rare disease on patients and their families, presents strategies for recognizing signs and symptoms of HoFH, and reviews guidelines for genetic screening and referral of patients and their families...
2023-03-1134 min
PeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smarter Approaches for Diagnosing HoFHGo online to PeerView.com/BPX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While homozygous familial hypercholesterolemia (HoFH) is associated with development of atherosclerotic cardiovascular disease in childhood, early recognition and treatment of this inherited disease can improve outcomes for patients. In this animated activity provided by PeerView in collaboration with the Family Heart Foundation, a cardiologist describes the impact of this rare disease on patients and their families, presents strategies for recognizing signs and symptoms of HoFH, and reviews guidelines for genetic screening and referral of patients and their families...
2023-03-1135 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 minPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 minPeerView Internal Medicine CME/CNE/CPE Audio PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 min
PeerView Clinical Pharmacology CME/CNE/CPE VideoSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 minPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 minPeerView Internal Medicine CME/CNE/CPE Video PodcastSeth S. Martin, MD, MHS, FACC, FAHA, FASPC - Medicine in Motion: Smart Approaches for Treating HoFHGo online to PeerView.com/BNB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this animated activity, an expert on homozygous familial hypercholesterolemia (HoFH) discusses the latest data for novel lipid-lowering therapies and offers strategies for individualizing treatment regimens to improve outcomes for patients with HoFH. Upon completion of this activity, participants should be better able to: Apply standards of care to initiate and escalate lipid-lowering therapies in patients with HoFH; Distinguish the therapeutic characteristics of recently approved HoFH therapies according to their mechanisms of action; and Evaluate the benefits and...
2023-03-0425 min
Grown-Ass Woman's GuideThis Episode Could Save Your LifeWhy are so many women misinformed when it comes to heart disease? According to the CDC, about 1 in 16 women age 20 and older have coronary heart disease, and about 1 in every 5 female deaths are heart related. It is the leading killer of women in the United States and globally. But even today, and despite an increase in awareness, only about half of women recognize that heart disease is their number 1 killer.February is American Heart Month, a time to raise awareness of cardiovascular health. If we can make Heart Month half as popular as Breast Cancer Awareness month, I...
2023-02-0751 minObesity: A DiseaseEpisode 73: Article Reviews: Clinical Practice Statements for the Management of Obesity - Nutrition and Physical Activity, Part 2 of 2: Body CompositionOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category.
In our article review podcasts, we have carefully...
2022-12-1620 minObesity: A DiseaseEpisode 73: Article Reviews: Clinical Practice Statements for the Management of Obesity – Nutrition and Physical Activity, Part 2 of 2: Body CompositionOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category.
In our article review podcasts, we have carefully...
2022-12-1620 minObesity: A DiseaseEpisode 72: Article Reviews: Clinical Practice Statements for the Management of Obesity - Nutrition and Physical Activity, Part 1 of 2: Effective Patient Documentation; Electronic Medical Records (EMR's) and Energy ExpenditureOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category.
In our article review podcasts, we have carefully...
2022-12-1525 minObesity: A DiseaseEpisode 72: Article Reviews: Clinical Practice Statements for the Management of Obesity – Nutrition and Physical Activity, Part 1 of 2: Effective Patient Documentation; Electronic Medical Records (EMR’s) and Energy ExpenditureOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category.
In our article review podcasts, we have carefully...
2022-12-1525 min
For Your Health NewsChampions for Total Health: Hypertension and VaccinesYou're invited to join NMQF's Center for Sustainable Health Care Quality and Equity (SHC) for a Health Champions discussion on Hypertension and Vaccines, with a focus on flu and COVID-19 vaccination rates and additional inequities in the African American community.
Panelists
Yabo Beysolow, MD, MPH Technical consultant: Association of Immunization Managers (AIM); Immunize.org, WHO EURO Immunizations Pediatrician, Public Speaker
Laurence S. Sperling, MD, FACC, FAHA, FACP, FASPC Executive Director, Million Hearts Initiative, Division of Heart Disease and Stroke Prevention Centers for Disease Control and Prevention and the Center for Medicare and Medicaid Services
Kris...
2022-10-031h 04Obesity: A DiseaseEpisode 71: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Part 2 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program.
Today's topics include the management and care of patients with obesity following a cancer diagnosis; the need for aggressive treatment of obesity using behavioral, medical and surgical strategies; the benefits of weight loss in cancer patients with obesity; and the devastating...
2022-09-0918 minObesity: A DiseaseEpisode 71: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Part 2 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program.
Today's topics include the management and care of patients with obesity following a cancer diagnosis; the need for aggressive treatment of obesity using behavioral, medical and surgical strategies; the benefits of weight loss in cancer patients with obesity; and the devastating...
2022-09-0918 minObesity: A DiseaseEpisode 70: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Part 1 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program.
Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-0920 minObesity: A DiseaseEpisode 70: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Part 1 of 2OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program.
Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-0920 minObesity: A DiseaseEpisode 69: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Full PodcastOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program.
Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-0832 minObesity: A DiseaseEpisode 69: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Full PodcastOMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program.
Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-0832 min
The Pulse PodMillion Hearts 2027: A Conversation with Larry Sperling, MD, FACC, FACP, FAHA, FASPCTom sits down with Dr. Sperling to learn about the mission to prevent one million cardiovascular events in the next five years and what AACVPR members can do to support it.
2022-06-0125 minObesity: A DiseaseEpisode 64: Article Reviews: Clinical Practice Statements for the Management of Obesity; Part 3 of 3: Caloric Quality, Quantity and Physical Activity in Obesity ManagementIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews OMA Vice President Lydia Alexander, MD FOMA. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Alexander was first author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
Topics include the basics of macronutrients; The Dash diet and Mediterranean diet as preferred dietary patterns for the management of obesity; the implementation of the Mediterranean Diet; and the roles of Caloric quality, quantity, an...
2022-05-1019 minObesity: A DiseaseEpisode 63: Article Reviews: Clinical Practice Statements for the Management of Obesity; Part 2 of 3: The Dash Diet and Mediterranean Dietary Patterns In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews OMA Vice President Lydia Alexander, MD FOMA. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Alexander was first author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
Topics include the basics of macronutrients; The Dash diet and Mediterranean diet as preferred dietary patterns for the management of obesity; the implementation of the Mediterranean Diet; and the roles of Caloric quality, quantity, an...
2022-05-1016 minObesity: A DiseaseEpisode 62: Article Reviews: Clinical Practice Statements for the Management of Obesity; Part 1 of 3: Basics of MacronutrientsIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews OMA Vice President Lydia Alexander, MD FOMA. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Alexander was first author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
Topics include the basics of macronutrients; The Dash diet and Mediterranean diet as preferred dietary patterns for the management of obesity; the implementation of the Mediterranean Diet; and the roles of Caloric quality, quantity, an...
2022-05-1015 minObesity: A DiseaseEpisode 61: Article Reviews: Clinical Practice Statements for the Management of Obesity; Full PodcastIn this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews OMA Vice President Lydia Alexander, MD FOMA. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Alexander was first author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
Topics include the basics of macronutrients; The Dash diet and Mediterranean diet as preferred dietary patterns for the management of obesity; the implementation of the Mediterranean Diet; and the roles of Caloric quality, quantity, an...
2022-05-1038 minObesity: A DiseaseEpisode 60: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 3 of 3: TelehealthThis episode is a segment focusing on obesity Telehealth services from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted...
2022-04-0626 minObesity: A DiseaseEpisode 59: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 2 of 3:SOPsThis episode is a segment focusing on SOPs from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted to the publication of...
2022-04-0606 minObesity: A DiseaseEpisode 58: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 1 of 3: BiasThis episode is a segment focusing on weight bias Bias from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted...
2022-04-0609 minObesity: A DiseaseEpisode 57: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Full PodcastIn this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted to the publication of clinical and evidence-based research for...
2022-04-0535 min
Cardiometabolic Beat PodcastLooming Cardiometabolic Crisis: A Conversation about Race with Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLADespite therapeutic advances, the cardiometabolic disease burden remains disproportionally high in patients from racial and ethnic populations. The reasons for these disparities are complex and underlined by social determinants of health and limited access to appropriate healthcare, among other factors. During this webinar, Dr. Keith C. Ferdinand, MD, hosted a panel with key opinion leaders to discuss the current state of these disparities as well as strategies to better help close these gaps going forward. Recorded February 22, 2022
2022-02-2453 min
The Whole Health Cure"The Heart of Cardiovascular Prevention" with Laurence S. Sperling, MDIn this episode Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPC talks about prevention of heart disease. Dr. Sperling covers a range of topics related to cardiovascular disease and its prevention. What is preventive cardiology? How can we prevent heart disease in individuals and populations? What are the risk factors for heart disease? Dr. Sperling discusses the opportunities in healthcare as it relates to cardiovascular health, and why this topic is especially relevant in the time of the pandemic. Dr. Sperling talks about local and national projects he is leading to restore cardiovascular health and closes with tips...
2022-02-1136 min
Pri-Med News & Industry FeaturesShared decision-making in lipid managementOverview: This podcast discusses when patients who are at high risk of cardiovascular disease should be comanaged by primary care providers and lipidologists.
Guest: Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE
2021-12-2006 min
Pri-Med News & Industry FeaturesWhen is LDL-C low enough?Overview: This podcast discusses the management of low-density lipoprotein cholesterol (LDL-C) and addresses the concept of when LDL-C levels are “low enough” to reduce the risk for atherosclerotic cardiovascular disease.
Guest: Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE
2021-12-2005 min
Pri-Med News & Industry FeaturesEffects of long-term exposure to persistently elevated LDL-COverview:
This podcast discusses the effects of long-term exposure to persistently elevated low-density lipoprotein cholesterol (LDL-C) on risk for atherosclerotic cardiovascular disease. Four health care providers offer their perspectives from the fields of family medicine, internal medicine, cardiology, and endocrinology.
Guest:
Guy Mintz, MD, FACP, FACC, FASPC, FNLA & James Underberg, MD, PLCC
2021-12-2009 min
Pri-Med PodcastsPopulations at High-Risk for Influenza: Cardiometabolic DiseaseCredits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-3
Overview: Join us to discover why it is important to prevent influenza and treat patients with influenza who have cardiometabolic disease. After this brief podcast, you will be able to identify the types of cardiovascular and metabolic diseases that put patients at high risk of influenza complications and determine which patients should get the high-dose influenza vaccine, according to recent data. You will also be able to answer the question of whether anti-influenza drugs affect the risk of...
2021-10-1522 minObesity: A DiseaseEpisode 46: Article Reviews: Determinants of Weight Loss Maintenance
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC and Sarah Wells, MD discuss a recent article about the determinants of weight loss maintenance. Topics covered include what determinants were found to be positively predictive in weight loss maintenance, which determinants are non-significant for weight loss maintenance, and how to translate this article into clinical application.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive review of obesity medicine that...
2021-09-0313 minObesity: A DiseaseEpisode 44: Article Reviews: Patient Assisted Virtual PhysicalIn this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Carolynn Francavilla, MD, FOMA to discuss a recent article on virtual physicals using telehealth. Topics covered include: Individualizing the telehealth physical exam, limitations and opportunities of the telehealth exam, and challenges for prescribing anti-obesity medications by telehealth.
To access other resources from the clinical leader in Obesity Medicine, visit www.obesitymedicine.org.
Episode Guests
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Carolynn Francavilla, MD, FOMA
Resources Mentioned
The Telehealth Ten...
2021-08-0414 minObesity: A DiseaseEpisode 42: Article Reviews: Safety and Effectiveness of Longer-Term Phentermine Use
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Mahtab Ahmed, MD, FOMA, Dipl. ABOM about a recent article on the safety and effectiveness of longer-term Phentermine use. Topics covered include risks and benefits of prescribing Phentermine longer than 12 weeks, the impact of study results only including low cardiovascular disease risk patients and being a retrospective study, and the role of local regulations in prescribing.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which...
2021-06-3017 minObesity: A DiseaseEpisode 40: Article Reviews: Long-Term Weight Loss in the Diabetes Prevention Program
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Laura Davisson, MD, MPH, FACP, to discuss a recent article on the comparison of Metformin and lifestyle intervention in diabetes prevention. Topics covered include the success of the intensive lifestyle intervention of the Diabetes Prevention Program, the difficulty many patients have with weight loss maintenance, and the consideration of prescribing Metformin for prediabetes.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive...
2021-06-0712 minObesity: A DiseaseEpisode 38: Article Reviews: Stress and Obesity
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Angela Golden, DNP, FNP-C, FAANP, to discuss a recent article on the connection between stress and obesity. Topics covered include clinical strategies for talking to patients about stress and obesity, the role of obesity bias and stigma in increasing patient stress, and how to manage hormones related to stress.
Episode Guests
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Angela Golden, DNP, FNP-C, FAANP
Resources Mentioned
Tomiyama AJ: Stress and Obesity. Annu Rev...
2021-05-0313 minObesity: A DiseaseEpisode 37: Clinical Conversations: Anti-Obesity Medicines Under Development
In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.
You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at ww...
2021-04-1935 minObesity: A DiseaseEpisode 36: Clinical Conversations: Starting an Obesity Medicine Practice
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA to discuss her experience in starting an obesity medicine practice. Topics covered include: practice components and structure to consider when starting a practice, general business start-up practices, payment, and practice models, and recommended standard operating procedures.
To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org.
Episode Guests
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Karli Burridge, PA-C, MMS, FOMA
Resources Mentioned
2021-04-0533 min
The Whole Health CureRecast: "The Heart of Cardiovascular Prevention" with Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPCIn honor of February, Heart Health Month, we are recasting our favorite conversations with heart health experts!In this episode Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPC talks about prevention of heart disease. Dr. Sperling covers a range of topics related to cardiovascular disease and its prevention. What is preventive cardiology? How can we prevent heart disease in individuals and populations? What are the risk factors for heart disease? Dr. Sperling discusses the opportunities in healthcare as it relates to cardiovascular health, and why this topic is especially relevant in the time of the pandemic...
2021-02-1136 minObesity: A DiseaseEpisode 28: Article Reviews: PCOS and Obesity
Episode Description
n this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM and Sandra Christensen, MNS, ARNP, FOMA, discuss a recent article about polycystic ovary syndrome and obesity. Topics covered include health risks for women with PCOS and obesity, the connection among PCOS, obesity, and insulin resistance, impact of obesity treatment on fertility, and how treating obesity first improves the health of a woman with PCOS.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is...
2020-12-0714 min
CV NowCV Now Episode 013: Telemedicine in Underserved CommunitiesTo watch the discussion follow the link below:Impact of Telemedicine on CV Care for Underserved Communities (Ahmed M. Soliman, MD)We’d love to hear your thoughts on telemedicine’s role in underserved communities. Send us a tweet using #CVnow, and don’t forget to tag @debakeycveduSpeakers in this episode:Ahmed M. Soliman, MD, FACCAssociate Medical Director, Houston Methodist DeBakey Cardiovascular AssociatesCardiologist, Preventative CardiologyHouston Methodist Hospital Ami B. Bhatt, MD, FACCDirector, Outpatient Cardiology and TelecardiologyDi...
2020-07-2700 minCV NowCV Now Episode 010: Emerging Epidemics of Acute MI & Stroke in the YoungTo watch the discussion follow the link below:Emerging Epidemics of Acute MI & Stroke in the Young (Khurram Nasir, MD)Speakers on today's episode:Khurram Nasir, MD, MPH, MScChief, Division of Cardiovascular Prevention & WellnessCo-Director, Center for Outcomes ResearchHouston Methodist DeBakey Heart & Vascular CenterHouston Methodist Hospital Ron Blankstein, MDAssociate Director, Cardiovascular Imaging ProgramDirector, Cardiac Computed Tomography, Bringham and Women’s HospitalAssociate Professor of Medicine and Radiology, Harvard Medical School
2020-06-1500 minCV NowCV Now Episode 009: How Does COVID-19 Cause Cardiovascular Disease?To watch the discussion follow the link below:How Does COVID-19 Cause Cardiovascular Disease?Speakers on today's episode:John P. Cooke, MD, PhDJoseph C. “Rusty” Walter and Carole Walter Looke Presidential Distinguished Chair in Cardiovascular Disease Research, Department of Cardiovascular SciencesProfessor of Cardiovascular Sciences, Academic InstituteHouston Methodist Leslie T. Cooper, Jr., MDProfessor of Medicine and Chair of Cardiovascular DepartmentMayo Clinic, Florida Martha Gulati, MD, MS, FACC, FAHA, FASPCDivision Chief of Car...
2020-06-0800 min
The Whole Health Cure"The Heart of Cardiovascular Prevention" with Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPCThis is a very special episode - Episode # 100! THANK YOU to everyone for your continued support!In this episode Laurence S. Sperling, M.D., FACC, FAHA, FACP, FASPC talks about prevention of heart disease. Dr. Sperling covers a range of topics related to cardiovascular disease and its prevention. What is preventive cardiology? How can we prevent heart disease in individuals and populations? What are the risk factors for heart disease? Dr. Sperling discusses the opportunities in healthcare as it relates to cardiovascular health, and why this topic is especially relevant in the time of the pandemic. Dr...
2020-05-1536 min
Wellness: Fact vs. FictionHappy Heart Month! Women’s Heart Health and Prevention with Martha Gulati MDHosted by: Dr. Danielle Belardo Instagram: @daniellebelardomd Twitter: @dbelardomd Facebook: Dr. Danielle Belardo, MD Danielle Belardo is a Preventive Cardiologist in Newport Beach, CA Learn more about Dr. Belardo here Read Dr. Belardo's Blog here: https://d-belardo-md.medium.com/ Produced by: Dr. Kasey Johnson Instagram: @drkaseyjohnson Also be sure to follow today's guest, Dr. Martha Gulati! Instagram: @drmarthagulati Twitter: @drmarthagulati In this brilliant episode with expert Cardiologist Dr. Martha Gulati, in less than 90 minutes you will learn everything you ever wanted to know about preventing, diagnosing, and treating cardiovascular disease. We discuss the epidemic of cardiovascular disease in women, and lear...
2020-01-311h 30
heartmatters by Boston HeartApo B - Who, What, When, Where, and WhyJoin Dharmesh Patel, MD, FACC, FACP, FASPC, FNLA who is a cardiologist at the Stern Cardiovascular Foundation and Boston Heart Medical Science Liaison Ann Sims as they discuss the benefits of looking beyond the basic lipid panel. Learn what studies and guidelines support using ApoB testing for CVD risk stratification, what patient populations are more likely to have a normal LDL-C and elevated ApoB and the role of small LDL particles in promoting atherosclerosis.
For more medical education resources please visit https://bostonheartdiagnostics.com/providers/medical-education/ or call Customer Care at 877.425.1252 to request to speak with a...
2019-05-0825 min
Lipid LuminationsUpdated NLA Recommendations for African American Patients
Host: Alan S. Brown, MD, FACC, FAHA, FNLA
Guest: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University School of Medicine in New Orleans, Louisiana. Dr. Ferdinand reviews the etiologies, diagnostic challenges, and management considerations for selective cardiac health issues prevalent in African American populations, from hypertension to coronary arterial calcium plaques to lipid levels. Supported by an Educational Grant from AstraZeneca.
2015-08-0317 min